MedPath

江西昂泰制药有限公司

Ownership
-
Established
2004-05-17
Employees
-
Market Cap
-
Website
www.angtai.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

12

NMPA:12

Drug Approvals

Aminophylline Tablets

Product Name
氨茶碱片
Approval Number
国药准字H36020010
Approval Date
Dec 12, 2022
NMPA

Norfloxacin Capsules

Product Name
诺氟沙星胶囊
Approval Number
国药准字H36020009
Approval Date
Aug 15, 2022
NMPA

Compound Sulfamethoxazole Tablets

Product Name
复方磺胺甲噁唑片
Approval Number
国药准字H36020013
Approval Date
Jul 18, 2022
NMPA

Compound Sulfamethoxazole Tablets

Product Name
复方磺胺甲噁唑片
Approval Number
国药准字H36020014
Approval Date
Jul 18, 2022
NMPA

Oxytetracycline Tablets

Product Name
土霉素片
Approval Number
国药准字H36020012
Approval Date
Jul 18, 2022
NMPA

Ursodeoxycholic Acid Tablets

Product Name
熊去氧胆酸片
Approval Number
国药准字H36020015
Approval Date
Jul 18, 2022
NMPA

Metamizole Sodium Tablets

Product Name
安乃近片
Approval Number
国药准字H36020011
Approval Date
Jul 18, 2022
NMPA

大七厘胶囊

Approval Number
国药准字Z20050144
Approval Date
Aug 13, 2020
NMPA

消糜阴道泡腾片

Approval Number
国药准字Z20050769
Approval Date
Aug 13, 2020
NMPA

Nabumetone Tablets

Product Name
萘丁美酮片
Approval Number
国药准字H36020149
Approval Date
Aug 13, 2020
NMPA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.